Ad is loading...
PZVSX
Price
$15.49
Change
-$0.15 (-0.96%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

PZVSX vs VISVX

Header iconPZVSX vs VISVX Comparison
Open Charts PZVSX vs VISVXBanner chart's image
Pzena Small Cap Value Investor
Price$15.49
Change-$0.15 (-0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
PZVSX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PZVSX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PZVSX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. PZVSX (62.3M). VISVX pays higher dividends than PZVSX: VISVX (1.90) vs PZVSX (0.12). PZVSX was incepted earlier than VISVX: PZVSX (9 years) vs VISVX (27 years). PZVSX is a more actively managed with annual turnover of: 28.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than PZVSX: VISVX (3000) vs PZVSX (5000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. PZVSX (22.61). VISVX return over 5 years is better than : 57.32 vs. PZVSX (40.97).
PZVSXVISVXPZVSX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD5.87815.43338%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets62.3M57.6B0%
Annual Yield % from dividends0.121.906%
Returns for 1 year22.6128.7179%
Returns for 3 years2.3313.2318%
Returns for 5 years40.9757.3271%
Returns for 10 yearsN/A108.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics